Objectives
==========

Antithrombin (AT) has been proven to have major impact on perioperative activation of the coagulation system. The aim of this prospective, controlled, single-blind clinical trial was to determine the impact of AT substitution on perioperative thrombin formation.

Methods
=======

Forty male coronary artery bypass graft patients participated in the trial. Prior to skin incision, 30 patients received AT according to a formula targeted at 120% AT activity before extracorporeal circulation (ECC), plus an additional 1000 U (group A, *n*= 10), 2000 U (group B, *n*= 10) or 3000 U (group C, *n*= 10) of AT in order to compensate for increased consumption during ECC. Control patients did not receive any AT substitution (group D, *n*= 10). The following parameters were determined perioperatively and until the fifth postoperative day: AT levels, parameters of coagulation activation (prothrombin fragment F~1.2~, thrombin--antithrombin complex, D-dimer), inflammation (IL-6) and myocardial perfusion (troponin). Statistical comparison between groups was performed using analysis of variance, followed by Fisher\'s PLSD (*P*\< 0.05) after ECC.

Results
=======

AT substitution resulted in a significant increase in AT during ECC and until the first postoperative day (POD1), followed by a steep decrease at days 2--5. AT substitution attenuated thrombin generation significantly, as indicated by decreased concentrations of prothrombin fragments F~1.2~, thrombin--antithrombin complexes and D-dimer at the end of surgery. Troponin was significantly higher during the postoperative period in patients who did not receive AT substitution (Fig. [1](#F1){ref-type="fig"}).

![Perioperative course of troponin. \**P*\< 0.05, versus groups A, B and C.](cc2147-1){#F1}

Conclusions
===========

A substantial decrease in AT must be taken into account not only during ECC but also in the early postoperative period, indicating major enhancement of coagulation activation. High-dose AT substitution attenuates coagulation activation significantly. Attenuation of hemostatic activation may reduce postoperative complications, as lower postoperative troponin levels may indicate in AT substituted patients.
